| Catalog Number |
03P87-25 |
| Medical Device Problem Code |
Incorrect, Inadequate or Imprecise Result or Readings (1535)
|
| Health Effect - Clinical Code |
No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
11/23/2022
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
Apoc incident#: (b)(4).Apoc labeling will be evaluated during the investigation as pertaining to the event.
|
| |
|
Event or Problem Description
|
|
On (b)(6) 2023, abbott point of care was contacted by a customer regarding act kaolin cartridges that yielded a discrepant result of >1000 on a 75 year female patient during a procedure.There was no additional information available at the time of this report.Return product is not available for investigation.Method date tested act (sec).I-stat on (b)(6) 2022 13:58 173, i-stat on (b)(6) 2022 14:12 144, i-stat on (b)(6) 2022 14:18 155, i-stat on (b)(6) 2022 14:39 >1000.Per i-stat system manual (art: 770715-00a), the i-stat kaolin activated clotting time (kaolinact) test is an in vitro diagnostic test that uses fresh, whole blood, and is used to monitor high-dose heparin anticoagulation frequently associated with cardiovascular surgery.At this time there is no reason to suspect a malfunction exists.The reporting decision was based on the limited information that suggests the product was not performing within the variability of the assay.The customer alleges a falsely depressed result of 155 seconds after dosing the patient with no increase.Following an extra bolus, the act went too high and resulted in >1000 seconds.There were no details/times presented for heparin and limited patient information.It is suspected that the patient may be heparin resistant.An investigation is underway.
|
| |
|
Event or Problem Description
|
|
Na.
|
| |
|
Additional Manufacturer Narrative
|
|
Apoc incident: # (b)(4).The investigation was completed on 28-feb-2023.A review of the device history record (dhr) confirmed the cartridge lot passed release specifications.Retained cartridge testing met the acceptance criteria in appendix 1 of q04.01.003 rev.Ak (product complaint level 2 and level 3 investigation procedure).No deficiency has been identified.
|
| |
|
Search Alerts/Recalls
|